StockWatch
·
HomeLiveWeekly

GLENMARK PHARMACEUTICALS LTD.

BSE: 532296

OverviewP/LShare Hold

Shareholding Trends

Ownership split

PromoterPublicOthers
0%20%40%60%Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Institutional detail

FII / FPIDII
7%14%21%27%Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Q4 FY2026

Corporate Events

Board MeetingGLENMARK
2026
29May

Board Meeting

The Board of Directors will meet to consider and approve the…

BSE Filing ↗
Board MeetingGLENMARK
2024
14Nov

Board Meeting

Consider and approve the Unaudited Financial Results

BSE Filing ↗
Board MeetingGLENMARK
2024
24May

Board Meeting

Consider and approve the Standalone and Consolidated Audited…

BSE Filing ↗
Board MeetingGLENMARK
2023
10Nov

Board Meeting

Consider and approve Unaudited Financial Results for the sec…

BSE Filing ↗
Board MeetingGLENMARK
2023
5Oct

Board Meeting

Consider and approve the Sale of Equity Shares of Glenmark L…

BSE Filing ↗
Board MeetingGLENMARK
2023
11Aug

Board Meeting

Consider and approve Unaudited Financial Results for the Fir…

BSE Filing ↗